The present invention provides a process for the preparation of agomelatine and its intermediate compounds. The invention also provides intermediate compounds of agomelatine represented by Formula IV Formula V and Formula VIII.

An extrusion process for preparation of solid dispersion of lopinavir and ritonavir carried out in twin screw extruder.

The present invention relates to a process for the preparation of pure meropenem trihydrate.

The present invention relates to extended release pharmaceutical compositions of paliperidone and process of preparation thereof.

The present invention relates to a process for the preparation of cis-intermediate of Formula II which is useful synthetic intermediates in the preparation of tadalafil.

The present invention relates to a process for the direct preparation of malic acid salt of sunitinib.

The present invention relates to a process for preparation of erlotinib of Formula I or its pharmaceutically acceptable salt thereof. The present invention also relates to process for the preparation of erlotinib trifluoroacetate. The present invention also relates to a nove-ICrystalline form of erlotinib trifluoroacetate designated as Form E and process for its preparation. The present invention further relates to process for the preparation of erlotinib hydrochloride from erlotinib trifluoroac...

The present invention relates to certain sulfone acetic acid derivatives of formula I as MMP inhibitor and processes for its syntheses. The invention also relates to pharmacological compositions containing the compounds of the present invention and methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple scleorisis, gingivitis, atheroscl...

The invention relates to crystalline barium salt of (S)-omeprazole which is (S)-5-methoxy-2-[[(4-methoxy-35-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.